Charles Smith Pays for 13 shares of Auburn National Bancorporation, Inc. (AUBN) in an Insider Trading; Pnc Financial Services Group Upped Its West Pharmaceutical Svsc (WST) Holding

April 16, 2018 - By Shannon Black

West Pharmaceutical Services, Inc. (NYSE:WST) Logo

Pnc Financial Services Group Inc increased West Pharmaceutical Svsc Inc (WST) stake by 92.55% reported in 2017Q4 SEC filing. Pnc Financial Services Group Inc acquired 9,238 shares as West Pharmaceutical Svsc Inc (WST)’s stock declined 13.33%. The Pnc Financial Services Group Inc holds 19,220 shares with $1.90M value, up from 9,982 last quarter. West Pharmaceutical Svsc Inc now has $6.61B valuation. The stock increased 0.65% or $0.58 during the last trading session, reaching $89.44. About 265,889 shares traded. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 6.37% since April 16, 2017 and is uptrending. It has underperformed by 5.18% the S&P500.

Among 6 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. West Pharmaceutical Services had 15 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was downgraded by Zacks on Tuesday, August 4 to “Hold”. As per Wednesday, September 21, the company rating was downgraded by Wells Fargo. Jefferies upgraded West Pharmaceutical Services, Inc. (NYSE:WST) rating on Friday, September 15. Jefferies has “Buy” rating and $115 target. The firm earned “Outperform” rating on Tuesday, March 22 by Wells Fargo. The company was initiated on Friday, January 8 by Janney Capital. Jefferies maintained it with “Hold” rating and $10000 target in Thursday, June 29 report. On Friday, October 28 the stock rating was upgraded by Wells Fargo to “Outperform”. As per Tuesday, October 17, the company rating was downgraded by Bank of America. The rating was maintained by Jefferies with “Hold” on Monday, September 11. Wells Fargo maintained the shares of WST in report on Friday, October 27 with “Outperform” rating.

Investors sentiment decreased to 1.17 in 2017 Q4. Its down 0.16, from 1.33 in 2017Q3. It is negative, as 19 investors sold WST shares while 97 reduced holdings. 48 funds opened positions while 88 raised stakes. 67.16 million shares or 1.36% less from 68.09 million shares in 2017Q3 were reported. State Of Alaska Department Of Revenue reported 0.01% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). 2,088 were accumulated by Grandfield And Dodd Limited Liability Corp. Moreover, National Bank & Trust Of New York Mellon has 0.02% invested in West Pharmaceutical Services, Inc. (NYSE:WST). Comerica National Bank holds 0.04% or 62,742 shares in its portfolio. Sei Invs Co has 36,328 shares. Counselors owns 9,539 shares. Bnp Paribas Arbitrage Sa reported 15,219 shares. Moreover, Fdx Advsrs has 0.02% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 6,778 shares. Emerald Advisers Pa has 0.01% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 2,520 shares. Rhumbline Advisers reported 172,339 shares or 0.03% of all its holdings. Bessemer accumulated 7,064 shares. Koch holds 0.15% or 10,513 shares in its portfolio. Citigroup Inc holds 0% or 6,933 shares. 709,645 were reported by Eagle Asset. American Century Cos holds 0.07% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST) for 669,842 shares.

Pnc Financial Services Group Inc decreased Vmware Inc (NYSE:VMW) stake by 4,062 shares to 8,878 valued at $1.11M in 2017Q4. It also reduced Ishares Tr (IWB) stake by 38,613 shares and now owns 2.53M shares. Rockwell Collins Inc (NYSE:COL) was reduced too.

Since December 8, 2017, it had 0 buys, and 1 insider sale for $2.08 million activity. On Friday, December 8 FEDERICI WILLIAM J sold $2.08 million worth of West Pharmaceutical Services, Inc. (NYSE:WST) or 21,000 shares.

Since October 18, 2017, it had 7 buys, and 0 insider sales for $5,761 activity. 794 shares valued at $28,024 were sold by WRIGHT EMIL F JR on Wednesday, October 18. 35 shares valued at $1,344 were bought by Barrett J Tutt on Thursday, January 11. 13 Auburn National Bancorporation, Inc. (NASDAQ:AUBN) shares with value of $500 were bought by O’DONNELL SHANNON. The insider HAM WILLIAM F JR bought $1,036. Shares for $539 were bought by SMITH CHARLES EDWARD JR on Thursday, January 11. Another trade for 32 shares valued at $1,228 was bought by ANDRUS TERRY W. 24 shares were bought by HOUSEL DAVID E, worth $921 on Thursday, January 11.

Auburn National Bancorporation, Inc

Investors sentiment increased to 1.75 in 2017 Q4. Its up 0.50, from 1.25 in 2017Q3. It is positive, as 1 investors sold Auburn National Bancorporation, Inc. shares while 3 reduced holdings. 1 funds opened positions while 6 raised stakes. 274,421 shares or 14.07% more from 240,580 shares in 2017Q3 were reported. Wells Fargo And Mn has invested 0% in Auburn National Bancorporation, Inc. (NASDAQ:AUBN). Blackrock owns 0% invested in Auburn National Bancorporation, Inc. (NASDAQ:AUBN) for 988 shares. Regions Fincl Corp owns 0% invested in Auburn National Bancorporation, Inc. (NASDAQ:AUBN) for 4,038 shares. Lincoln holds 0.04% of its portfolio in Auburn National Bancorporation, Inc. (NASDAQ:AUBN) for 36,460 shares. Banc Funds has invested 0.2% in Auburn National Bancorporation, Inc. (NASDAQ:AUBN). Kennedy Mngmt Inc owns 20,948 shares or 0.01% of their US portfolio. Dimensional Fund Advisors Ltd Partnership stated it has 0% in Auburn National Bancorporation, Inc. (NASDAQ:AUBN). Suntrust Banks reported 39,527 shares. Us Comml Bank De reported 11,889 shares. 600 were accumulated by Fincl Bank Of America De. Morgan Dempsey Cap owns 18,924 shares or 0.24% of their US portfolio. Royal Bancorp Of Canada accumulated 201 shares. Stevens First Principles Inv invested in 0.02% or 1,000 shares. Morgan Stanley holds 0% or 201 shares.

West Pharmaceutical Services, Inc. (NYSE:WST) Institutional Positions Chart